Angiogenesis Inhibitors: all 4,430 studies that test it
Page 41 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular EdemaCompletedNCT00403039Phase 1
- Intravitreal Bevacizumab for Retinal DisordersStatus unknownNCT00403026Not applicable
- Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard TherapyTerminatedNCT00402415Phase 1
- A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic CancerCompletedNCT00401570Phase 2
- Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal CancerCompletedNCT00400114Phase 2
- Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1
- Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple MyelomaCompletedNCT00398515Phase 1
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineCompletedNCT00397787Phase 2
- Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple MyelomaCompletedNCT00396045Phase 1/2
- Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular DegenerationCompletedNCT00395707Phase 1/2
- Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.CompletedNCT00395551Phase 1
- Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid TumorsCompletedNCT00395434Phase 1
- Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal CancerTerminatedNCT00394992Phase 3
- A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer TreatmentCompletedNCT00393497Phase 1
- Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis PatientsWithdrawnNCT00390247Phase 4
- Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular DegenerationCompletedNCT00390208Phase 2
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- The Avastin vs Visudyne for Neovascular AMD StudyWithdrawnNCT00390026Phase 3
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
- A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal CancerWithdrawnNCT00388700Phase 2
- Sunitinib in Treating Young Patients With Refractory Solid TumorsCompletedNCT00387920Phase 1
- Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00387699Phase 2
- Efficacy Study of Lucentis in the Treatment of Diabetic Macular EdemaCompletedNCT00387582Phase 2
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
- Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer TrialCompletedNCT00386828Phase 2
- ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal CancerTerminatedNCT00385021Phase 2
- Intravitreal Bevacizumab for Neovascular GlaucomaCompletedNCT00384631Not applicable
- Randomized Trial of ATN-224 and Temozolomide in Advanced MelanomaStatus unknownNCT00383851Phase 2
- Intravitreal Bevacizumab for Polypoidal Choroidal VasculopathyStatus unknownNCT00383812Not applicable
- Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMDCompletedNCT00383370Phase 1
- Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the UterusCompletedNCT00378911Phase 2
- Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) TrialCompletedNCT00378196Phase 1
- Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon CancerCompletedNCT00378066Phase 2
- Combination Therapy for Age-Related Macular Degeneration.CompletedNCT00376701Phase 2
- An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMDCompletedNCT00373659Phase 2
- Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma PatientsCompletedNCT00373646Phase 2
- Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell CarcinomaCompletedNCT00372853Phase 1
- Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell CancerCompletedNCT00371553Phase 2
- Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical TrialCompletedNCT00370851Phase 3
- Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)CompletedNCT00370786Phase 3
- Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)Status unknownNCT00370721Phase 3
- Effect of Intravitreal Bevacizumab on Clinically Significant Macular EdemaStatus unknownNCT00370669Phase 3
- Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)Status unknownNCT00370630Phase 2
- Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDStatus unknownNCT00370539Phase 3
- Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialStatus unknownNCT00370422Phase 3
- Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDStatus unknownNCT00370370Phase 3
- A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic CancerCompletedNCT00369889Phase 2
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
- A Study of Volociximab in Metastatic MelanomaTerminatedNCT00369395Phase 2
- Treatment of Newly Diagnosed Elderly Patients With Multiple MyelomaCompletedNCT00367185Phase 3
- SU011248 in Advanced Hepatocellular CarcinomaCompletedNCT00361309Phase 2
- SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerTerminatedNCT00361244Phase 1/2
- Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma PatientsCompletedNCT00358020Phase 2
- Bevacizumab and Sunitinib in Treating Patients With Solid TumorsCompletedNCT00357318Phase 1
- Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNCT00354549Phase 2
- A Study of ATN-224 and Bortezomib in Patients With Multiple MyelomaTerminatedNCT00352742Phase 1/2
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaCompletedNCT00352521Phase 2
- Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerCompletedNCT00349557Phase 2
- TCD Followed by autoSCT for Newly Diagnosed MM PatientsStatus unknownNCT00349115Phase 2
- Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerStatus unknownNCT00348998Phase 2
- Bevacizumab and Retinal Vascular OcclusionsWithdrawnNCT00347711Phase 3
- Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyWithdrawnNCT00347698Phase 2/3
- Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal CancerCompletedNCT00345761Phase 1/2
- 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.CompletedNCT00345696Phase 2
- Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous MaculopathyStatus unknownNCT00344617Phase 3
- Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)CompletedNCT00344227Phase 2
- Preop Chemoradiation Resectable PancreasCompletedNCT00336648Phase 2
- Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
- A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationTerminatedNCT00333476Phase 2
- Sunitinib Malate With Hormonal Ablation for Patients Who Will Have ProstatectomyActive, not recruitingNCT00329043Phase 2
- Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver MetastasesTerminatedNCT00327093Phase 4
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's LymphomaCompletedNCT00322985Phase 2
- Phase 1 Study of VEGF Trap in Patients With Diabetic Macular EdemaCompletedNCT00320814Phase 1
- Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMDCompletedNCT00320775Phase 1
- PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple MyelomaStatus unknownNCT00319865Phase 2
- Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity LymphedemaStatus unknownNCT00318513Phase 1
- A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerCompletedNCT00317200Phase 2
- Use of Thalidomide in Chronic UveitisTerminatedNCT00314665Phase 4
- Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2
- Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00309998Phase 2
- Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic MelanomaCompletedNCT00308607Phase 2
- Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00306813Phase 1/2
- Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00305825Phase 2
- Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple MyelomaCompletedNCT00305812Phase 2
- SARCOTHAL. Thalidomide in Skin SarcoidosisCompletedNCT00305552Phase 3
- Temodar and Sutent as Therapy for MelanomaTerminatedNCT00304200Phase 1/2
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00301990Phase 2
- Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic PainTerminatedNCT00301405Phase 2
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular DegenerationCompletedNCT00288561Phase 2
- Use of Thalidomide in Patients With ArachnoiditisCompletedNCT00284505Phase 2
- Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular CarcinomaTerminatedNCT00280007Phase 2
- Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00278187Phase 2
- Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerStatus unknownNCT00276705Phase 2